Back to Assenagon Asset Management S.A. Assenagon Asset Management S.A.

RARERARE
Showing 9 of 22 quarters

Position history for Assenagon Asset Management S.A.Assenagon Asset Management S.A.'s holdings in ULTRAGENYX PHARMACEUTICAL IN

Assenagon Asset Management S.A. holds 120,864 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $4M as of 2026-Q2. The position was decreased (-94.7% shares). RARE represents 0.0% of Assenagon Asset Management S.A.'s portfolio.

Current Value

$4M

Current Shares

120,864

Total Value Change

-$1.8M

Total Shares Change

-21,310

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
120,864
-94.7%
$4M0.0%$25.00
0
2026-Q1
Increased
2.3M
+1030.4%
$47.3M0.1%$22.07
47
2025-Q4
Decreased
199,720
-21.0%
$4.6M0.0%$22.78
0
2025-Q3
Decreased
252,669
-78.3%
$7.6M0.0%$30.36
0
2025-Q2
Increased
1.2M
+439.1%
$42.3M0.1%$36.52
47
2025-Q1
Increased
215,890
+211.7%
$7.8M0.0%$37.82
44
2024-Q4
Decreased
69,273
-52.4%
$2.9M0.0%$42.27
0
2024-Q3
Increased
145,433
+2.3%
$8.1M0.0%$54.43
28
2024-Q2
Unchanged
142,174
0.0%
$5.8M0.0%$41.10
0

Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used